ERBB2 and breast carcinoma: A polymorphism of the HER‐2 gene that results in the substitution of isoleucine‐to‐valine atcodon 655 of the transmembrane domain (Ile655Val, rs1136201) has been extensively investigated as a risk factor for breast cancer 73.